1006-17: Early Assessment, Diagnosis and Treatment of Pediatric Delirium

4.55 (11 votes)

  • Registration Closed

1006-17: Early Assessment, Diagnosis and Treatment of Pediatric Delirium

This session will enable the learner to improve both their knowledge and skills related to early assessment, detection and nursing care to patients with pediatric delirium.

Presenter: Nancy Noyes, RN, MS, PPCNP-BC, PMHCNS-BC

Disclosures: Discussion of off-label uses (using products for a purpose other than that for which it was approved by the Food and Drug Administration, or FDA) will occur in this presentation.

Session Length:  1 hour 5 minutes

Target Audience: RN, APRN 

Session Objectives:
Upon completion of this presentation, the participant will be able to:

  1. Identify DSM-5 Diagnostic Criteria for pediatric delirium.
  2. Define core signs and symptoms of pediatric delirium.
  3. Describe etiology and risk factors for the development of pediatric delirium.
  4. Understand the pathophysiology of pediatric delirium.
  5. Discuss the differential diagnosis of pediatric delirium.
  6. Identify evidence-based screening tools utilized in the diagnosis of pediatric delirium.
  7. Identify pharmacologic and non-pharmacologic treatment strategies of pediatric delirium.

Keywords: Pediatric Delirium, Child & Adolescent, Practice, Pharmacology

Continuing Nursing Education
1.0 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation and earn a passing score on the post test before the expiration date. You will have 5 tries to correctly answer the questions on the post test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Originally Presented
APNA 15th Annual Clinical Psychopharmacology Institute
Hyatt Regency Baltimore on the Inner Harbor
Friday, June 9, 2017
3:30pm – 5:00pm

The contact hours for this session expire: July 1, 2019

Components visible upon registration.